FibroBiologics, Inc. (FBLG)

FibroBiologics Statistics

Total Valuation

FibroBiologics has a market cap or net worth of $371.03 million. The enterprise value is $364.98 million.

Market Cap	371.03M
Enterprise Value	364.98M

Important Dates

The last earnings date was Tuesday, May 14, 2024, after market close.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

FibroBiologics has 32.72 million shares outstanding. The number of shares has increased by 10.28% in one year.

Shares Outstanding	32.72M
Shares Change (YoY)	+10.28%
Shares Change (QoQ)	+10.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$2.25M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	10.62
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.79
Average Volume (30 Days)	68,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	-22.53M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$0.69

Balance Sheet

The company has $8.16 million in cash and $2.11 million in debt, giving a net cash position of $6.05 million or $0.18 per share.

Cash & Cash Equivalents	8.16M
Total Debt	2.11M
Net Cash	6.05M
Net Cash Per Share	$0.18
Equity / Book Value	-3.86M
Book Value Per Share	-0.12
Working Capital	-5.06M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FibroBiologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.28%
Shareholder Yield	-10.28%
Earnings Yield	-6.07%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a